The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Sitagliptin Monotherapy

P. Fouqueray, V. Pirags, M. Diamant, G. Schernthaner, H.E. Lebovitz, S.E. Inzucchi, C.J. Bailey

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1924-1930
JournalDiabetes Care
Volume37
Issue number7
DOIs
Publication statusPublished - 2014

Cite this

Fouqueray, P., Pirags, V., Diamant, M., Schernthaner, G., Lebovitz, H. E., Inzucchi, S. E., & Bailey, C. J. (2014). The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Sitagliptin Monotherapy. Diabetes Care, 37(7), 1924-1930. https://doi.org/10.2337/dc13-2349